Offering Genetic Testing at Point of Care Could Increase Uptake
New findings suggest offering genetic testing at the point of care along with a digital cancer risk assessment could increase uptake.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2023 | Point-of-Care |
New findings suggest offering genetic testing at the point of care along with a digital cancer risk assessment could increase uptake.
Read MorePosted by Andy Lundin | Mar 30, 2023 | Prostate |
A rapid test for advanced prostate cancer can quickly identify people with “actionable” gene variants eligible for new targeted therapies.
Read MorePosted by Andy Lundin | Mar 17, 2023 | Disease States |
Multiple sclerosis experts are advocating for genetic testing to identify MS patients at risk of developing side effects from medications.
Read MorePosted by Andy Lundin | Mar 7, 2023 | Molecular Diagnostics |
Research on the genetics of cerebral palsy offers evidence that genetic testing should be offered as standard for people with the disorder.
Read MorePosted by Chris Wolski | Dec 23, 2022 | Cancer, Sequencing Systems |
Researchers have made an advancement in genetic testing that allows for more accurate prediction of individual’s increased cancer risk.
Read More